5,0
26 aug 2025
Anonieme werknemer
Voormalige werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Amazing intellectual atmosphere for R&D
Minpunten
Effectively assimilated by Roche and now just another mega-corp; pay is slightly below market rate as they see themselves as “the Harvard of industry.” Senior management makes big slash and burn cuts irrespective of contribution or potential, and pipeline is deeply questionable